CVS to Pay $36.5 Million in Multistate Settlement Over Alleged Over-Dispensing of Insulin Pens
CVS Pharmacy, Inc. has agreed to pay $36.5 million to settle allegations that it submitted false claims to Medicaid and other government health programs by dispensing more insulin pens than patients needed, according to the U.S. Department of Health and Human Services Office of Inspector General (HHS OIG) on July 9, 2026. The agreement involves the federal government and 37 state attorneys general.
The HHS OIG page compiles announcements from several participating jurisdictions. Massachusetts described collaboration with the U.S. Department of Justice and 35 other state attorneys general. Connecticut described an agreement involving the United States, the District of Columbia, and 35 other states. Minnesota described the group as a coalition of 37 attorneys general and the federal government.
A multistate investigation led by attorneys general from Massachusetts, Minnesota, Connecticut, Hawaii, and others, along with the U.S. Department of Justice, examined CVS’s dispensing practices. Government press releases state that CVS provided insulin pens in quantities exceeding medical necessity and then billed government health programs, including state Medicaid agencies, for those amounts. Officials allege these actions led to false claims in violation of state and federal law.
Several states have released details about their share of the settlement. Massachusetts Attorney General Andrea Joy Campbell said Massachusetts will receive $1.3 million. Minnesota Attorney General Keith Ellison reported Minnesota will receive over $850,000, with more than $400,000 going directly to the state’s Medical Assistance Program. Connecticut Attorney General William Tong stated Connecticut’s Medicaid program will receive $1,089,945.85, of which $633,913.76 is the state’s share. Hawaii Attorney General Anne Lopez said Hawaii will receive $617,160.
The settlement resolves claims that CVS dispensed more insulin pens than necessary for individual patients, resulting in excessive charges to government health programs. The agreement does not include a finding or admission of liability.
HHS OIG and state authorities said the settlement recovers funds for federal and state Medicaid programs and is part of ongoing efforts to address health care fraud. Settlement funds will be distributed among the federal government and participating states, with some amounts going directly to Medicaid programs.
CVS will pay the $36.5 million settlement to resolve these civil allegations. The government announcement notes the settlement does not determine liability.
Under the agreement, CVS must pay the settlement amount to the federal government and the participating jurisdictions. Each Medicaid program will receive its share as described in the settlement. The government announcement did not specify additional enforcement actions or compliance requirements.
This article is for general information only and is not legal advice.